AstraZenecas

Medical syringes and small figurines of people are seen in front of the AstraZeneca logo displayed on a screen. On Saturday, March 26, 2021, in Dublin, Ireland. NurPhoto | NurPhoto …

South Africa announced this week that it’s stopping the use of the AstraZeneca-Oxford COVID-19 vaccine after a small study found that it wasn’t effective against mild and moderate disease. Other …

The French guidance differs from that given by the European Medicines Agency, which authorized AstraZeneca’s vaccine for use in all adults throughout the European Union Representational image. AP Paris: France’s …

Topline Ahead of its expected approval for use by Europe’s medicines regulator Friday, Germany’s vaccine committee has recommended against giving AstraZeneca’s Covid-19 vaccine to people over the age of 65, …

China’s Walvax Biotechnology Co has started work on a plant to manufacture an early-stage coronavirus vaccine candidate similar to AstraZeneca PLC’s product, state-backed media said on Sunday. Mass production for …

The study published in the Lancet showed the vaccine had an efficacy of 62 percent for those given two full doses, and of 90 percent in those given a half …

Oversight has been weak, contributing to a spate of scandals over substandard vaccines. While the government after each incident has vowed to do more to clean up the industry, regulators …

AstraZeneca and the University of Oxford announced on Monday that their inexpensive, easy-to-produce coronavirus vaccine appears effective, the latest in a string of encouraging results this month from leading vaccine …

The vaccine, developed with the University of Oxford, showed 90% efficacy in one dosing regimen — when the vaccine was given as a half dose, followed by a full dose …